• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

France: Influenza A (H1N1): a man treated with Tamiflu died

Gert van der Hoek

In Memoriam - Editor, Senior Moderator
Influenza A (H1N1): a man treated with Tamiflu died in Unieux

A man aged 58, suffering from influenza A (H1N1) and treated with Tamiflu died
Monday morning at his home in Unieux. Doctors said his death was
caused by cardiac arrest.
See also :http://www.flutrackers.com/forum/showthread.php?t=126079

Based on laboratory tests, the authorities of Denmark, Japan and
Special Administrative Region of Hong Kong has informed WHO of the outbreak of
virus
H1N1 resistance to oseltamivir (antiviral drug known to
Tamiflu). These viruses were found in three patients who were not
seriously ill and have all healed.

Investigations have found no resistant virus among close contacts
these three people. Although resistant to oseltamivir, the viruses were
still sensitive to zanamivir.

Laboratories Network Global Influenza Surveillance examined the
antiviral resistance to almost 1000 pandemic H1N1 virus. In all
Otherwise, they were both sensitive to oseltamivir than zanamivir. WHO
and its partners will continue monitoring the resistance of influenza viruses
antivirals.

Based on current information, these cases of resistance seem to
sporadic. Currently, there is no development of a
extent of antiviral drug resistance among H1N1 pandemic virus. Following
this risk assessment, WHO does not change its guidelines for
treatment. Antiviral drugs are an essential element of the Action
public health when used as recommended.

http://buzzsante.com/epidemies-pand...me-soigne-au-tamiflu-meurt-a-unieux-1701.html
 
Back
Top